User contributions for Jerneja Nimac

10 May 2021

• 20:3220:32, 10 May 2021 diff hist +1‎ Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli ‎ →‎Proizvodnja škrlatnega barvila v E. coli in barvanje tkanin current
• 20:3220:32, 10 May 2021 diff hist 0‎ Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli ‎ →‎Vzpostavitev poti – od triptofana do 6-bromoindola
• 18:2918:29, 10 May 2021 diff hist +13‎ Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli ‎No edit summary
• 18:2218:22, 10 May 2021 diff hist +4‎ Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli ‎No edit summary
• 18:2018:20, 10 May 2021 diff hist +397‎ MBT seminarji 2021 ‎No edit summary
• 18:0118:01, 10 May 2021 diff hist +5,921‎ N Proizvodnja škrlatnega indigoidnega barvila iz triptofana v bakteriji Escherichia coli ‎ New page: Škrlat je starodavno barvilo, ki so ga v preteklosti pridobivali iz prekurzorja ekstrahiranega iz mediteranskih morskih polžkov iz družine ''Muricidae''^1,2. Glavna komponenta...

8 April 2021

• 14:1614:16, 8 April 2021 diff hist +116‎ Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) ‎No edit summary current
• 14:1514:15, 8 April 2021 diff hist +11,517‎ N Cepivo proizvajalca Pfizer / BioNTech - optimizacija zaporedja molekule mRNA ‎ New page: Podjetji Pfizer in BioNTech sta se septembra 2020 odločili, da objavita celotno zaporedje molekule mRNA, ki jo vsebuje njihovo cepivo Comirnaty¹ in nosi zapis za celoten protei... current

31 March 2021

• 08:2508:25, 31 March 2021 diff hist +10‎ Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) ‎No edit summary

30 March 2021

• 19:4619:46, 30 March 2021 diff hist +4‎ Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) ‎No edit summary
• 19:4419:44, 30 March 2021 diff hist +2‎ Protikovidna cepiva ‎No edit summary
• 19:4319:43, 30 March 2021 diff hist +71‎ N Značilnosti cepiva proizvajalca Pfizer/BioNTech (mRNA) ‎ Značilnosti cepiva proizvajalca Pfizer/BioNTech (mRNA) moved to Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) current
• 19:4319:43, 30 March 2021 diff hist 0‎ m Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) ‎ Značilnosti cepiva proizvajalca Pfizer/BioNTech (mRNA) moved to Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA)
• 19:4019:40, 30 March 2021 diff hist +2‎ Protikovidna cepiva ‎No edit summary
• 19:3719:37, 30 March 2021 diff hist +5,099‎ N Značilnosti cepiva proizvajalca Pfizer / BioNTech (mRNA) ‎ New page: Cepivo pod lastniškim imenom Comirnaty (BNT162b2, nelastniško: Tozinameran) sta v sklopu projekta 'Svetlobna hitrost' razvili farmacevtski podjetji BioNTech in Pfizer^1-3. Cepi...

14 May 2020

• 08:0908:09, 14 May 2020 diff hist +4‎ Seminarji SB 2019/20 ‎No edit summary
• 08:0508:05, 14 May 2020 diff hist +161‎ Seminarji SB 2019/20 ‎No edit summary

13 May 2020

• 09:2109:21, 13 May 2020 diff hist +257‎ Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami ‎ →‎Pomen sinteznih konzorcijev current
• 09:1909:19, 13 May 2020 diff hist 0‎ Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami ‎ →‎Prostorska dinamika treh simetričnih ekosistemov

10 May 2020

• 11:4711:47, 10 May 2020 diff hist +8‎ Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami ‎No edit summary
• 11:4511:45, 10 May 2020 diff hist −1‎ Seminarji SB 2019/20 ‎No edit summary
• 11:4211:42, 10 May 2020 diff hist +204‎ Seminarji SB 2019/20 ‎No edit summary
• 11:4011:40, 10 May 2020 diff hist +12,481‎ N Načrtovanje mikrobnih konzorcijev z določenimi družbenimi interakcijami ‎ New page: '''''Povzeto po članku:''''' [https://www.nature.com/articles/s41589-018-0091-7 Kong, W., Meldgin, D. R., Collins, J. J. in Lu, T. Designing microbial consortia with defined social intera...

3 May 2020

• 10:2210:22, 3 May 2020 diff hist +138‎ ALiVE – analiza živih celic z vezikularnim izvozom ‎ →‎Ideja current
• 10:1710:17, 3 May 2020 diff hist +77‎ ALiVE – analiza živih celic z vezikularnim izvozom ‎ →‎Rezultati
• 09:4209:42, 3 May 2020 diff hist 0‎ ALiVE – analiza živih celic z vezikularnim izvozom ‎ →‎ALiVE kot diagnostično orodje za beta celično terapijo'
• 09:4009:40, 3 May 2020 diff hist +159‎ Seminarji SB 2019/20 ‎No edit summary
• 09:3709:37, 3 May 2020 diff hist +9,802‎ N ALiVE – analiza živih celic z vezikularnim izvozom ‎ New page: Spletna stran projekta ALiVE, iGEM 2019, https://2019.igem.org/Team:Munich Skupina iz Municha je na tekmovanju iGEM leta 2019 razvila študentski projekt z naslovom ALiVE. Cilj projekta j...

10 April 2020

• 13:1013:10, 10 April 2020 diff hist −86‎ Seminarji SB 2019/20 ‎No edit summary

8 April 2020

• 21:2221:22, 8 April 2020 diff hist +1‎ Seminarji SB 2019/20 ‎No edit summary
• 21:2121:21, 8 April 2020 diff hist +41‎ Seminarji SB 2019/20 ‎No edit summary

31 March 2020

• 07:0207:02, 31 March 2020 diff hist +11‎ Seminarji SB 2019/20 ‎No edit summary

10 March 2020

• 06:4906:49, 10 March 2020 diff hist +15‎ Seminarji SB 2019/20 ‎No edit summary

7 March 2020

• 19:4719:47, 7 March 2020 diff hist +451‎ Seminarji SB 2019/20 ‎No edit summary

16 March 2018

• 10:2910:29, 16 March 2018 diff hist +25‎ Molekularna biologija virusov ‎No edit summary

15 March 2018

• 17:3617:36, 15 March 2018 diff hist +33‎ Molekularna biologija virusov ‎No edit summary

1 December 2017

• 20:5620:56, 1 December 2017 diff hist +1,839‎ BIO2 Povzetki seminarjev 2017 ‎ →‎Biokemija- Povzetki seminarjev 2017/2018

24 November 2017

• 21:3921:39, 24 November 2017 diff hist +125‎ BIO2 Seminar 2017 ‎ →‎Seznam seminarjev
• 21:3521:35, 24 November 2017 diff hist +1,520‎ BIO2 Povzetki seminarjev 2017 ‎ →‎Biokemija- Povzetki seminarjev 2017/2018

12 November 2017

• 10:1210:12, 12 November 2017 diff hist +40‎ BIO2 Seminar 2017 ‎ →‎Seznam seminarjev

14 March 2017

• 16:2816:28, 14 March 2017 diff hist +1,326‎ TBK2017 Povzetki seminarjev ‎ →‎Ana Scott: Naslov seminarja

4 March 2017

• 13:2013:20, 4 March 2017 diff hist +130‎ TBK2017-seminar ‎ →‎Seznam seminarjev